Zobrazeno 1 - 10
of 506
pro vyhledávání: '"de Bont, ESJM"'
Autor:
de Camargo Magalhães ES; Department of Ageing Biology/ERIBA, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Glial Cell Biology Laboratory, Biomedical Sciences Institute, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., de Bont ESJM; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Division of Pediatric Oncology/Hematology, Groningen, the Netherlands., Bruggeman SWM; Department of Ageing Biology/ERIBA, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: s.w.m.bruggeman@umcg.nl., Lima FRS; Glial Cell Biology Laboratory, Biomedical Sciences Institute, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. Electronic address: flima@icb.ufrj.br.
Publikováno v:
Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2024 Aug; Vol. 1870 (6), pp. 167248. Date of Electronic Publication: 2024 May 21.
Autor:
van Dijk AD; Division of Pediatric Oncology and Hematology, Department of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Hoff FW; Division of Pediatric Oncology and Hematology, Department of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Qiu Y; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Hubner SE; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Go RL; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Ruvolo VR; Department of Molecular Therapy and Hematology, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Leonti AR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Gerbing RB; COG Statistics and Data Center, Monrovia, CA 91016, USA., Gamis AS; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO 64108, USA., Aplenc R; Division of Pediatric Oncology and Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Kolb EA; Nemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for Children, Wilmington, DE 19803, USA., Alonzo TA; COG Statistics and Data Center, Monrovia, CA 91016, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA 90007, USA., Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., de Bont ESJM; Division of Pediatric Oncology and Hematology, Department of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands., Horton TM; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX 77030, USA., Kornblau SM; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Apr 09; Vol. 16 (8). Date of Electronic Publication: 2024 Apr 09.
Autor:
van Dijk AD; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, Groningen, the Netherlands. a.d.van.dijk@umcg.nl., Griffen TL; Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA., Qiu YH; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hoff FW; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, Groningen, the Netherlands., Toro E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ruiz K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ruvolo PP; Department of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lillard JW Jr; Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA., de Bont ESJM; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, Groningen, the Netherlands., Burger JA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kornblau SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia [Leukemia] 2022 Mar; Vol. 36 (3), pp. 712-722. Date of Electronic Publication: 2021 Oct 08.
Autor:
Hurkmans EGE; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Klumpers MJ; Department of Pediatrics, Radboud University Medical Center, Nijmegen, Netherlands., Dello Russo C; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, Liverpool, United Kingdom.; Department of Healthcare Surveillance and Bioethics, Section of Pharmacology, Università Cattolica del Sacro Cuore-Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., De Witte W; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Cleton-Jansen AM; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Vermeulen SH; Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands., Kaal S; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Flucke U; Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands., Gidding CEM; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Schreuder HWB; Department of Orthopedics, Radboud University Medical Center, Nijmegen, Netherlands., de Bont ESJM; Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands., Caron HN; Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, Netherlands., Gattuso G; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Schiavello E; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Terenziani M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Massimino M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., McCowage G; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia., Nagabushan S; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.; Discipline of Child and Adolescent Health, University of Sydney, Sydney, NSW, Australia., Limaye A; Department of Audiology, The Children's Hospital at Westmead, Sydney, NSW, Australia., Rose V; Department of Neuro-Otology, Royal Prince Alfred Hospital, University of Sydney, Sydney, NSW, Australia., Catchpoole D; Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia., Jorgensen AL; Department of Health Data Science, University of Liverpool, Liverpool, United Kingdom., Barton C; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom., Delaney L; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom., Hawcutt DB; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom.; NIHR Alder Hey Clinical Research Facility, Alder Hey Children's Hospital, Liverpool, United Kingdom., Pirmohamed M; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Pizer B; Department of Pediatric Oncology, Alder Hey Children's Hospital, Liverpool, United Kingdom., Coenen MJH; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Te Loo DMWM; Department of Pediatrics, Radboud University Medical Center, Nijmegen, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2023 Jan 09; Vol. 13, pp. 980309. Date of Electronic Publication: 2023 Jan 09 (Print Publication: 2022).
Autor:
Hurkmans EGE; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Koenderink JB; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands., van den Heuvel JJMW; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands., Versleijen-Jonkers YMH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Hillebrandt-Roeffen MHS; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Groothuismink JM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Vos HI; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Flucke U; Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands., Muradjan G; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands., Schreuder HWB; Department of Orthopedics, Radboud University Medical Center, Nijmegen, Netherlands., Hagleitner MM; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Brunner HG; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Cleton-Jansen AM; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands., de Bont ESJM; Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands., Nijhoff GJ; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands., Kremer LCM; Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, Netherlands., Caron H; Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, Netherlands., Windsor R; Pediatric & Adolescent Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Patiño-García A; Department of Pediatrics, Clínica Universidad de Navarra, Solid Tumor Program, CIMA, Pamplona, Spain., González-Neira A; Human Genotyping Unit-CeGen, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Saletta F; Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia., McCowage G; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia., Nagabushan S; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.; Discipline of Child and Adolescent Health, University of Sydney, Sydney, NSW, Australia., Catchpoole D; Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia., Te Loo DMWM; Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, Netherlands., Coenen MJH; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Nov 09; Vol. 13, pp. 1042989. Date of Electronic Publication: 2022 Nov 09 (Print Publication: 2022).
Autor:
Hoff FW; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA., Van Dijk AD; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Qiu Y; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Hu CW; Department of Bioengineering, Rice University, Houston, TX, USA., Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Ligeralde A; Biophysics, University of California, Berkeley, CA, USA., Jenkins GN; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA., Gerbing RB; University of Southern California, Los Angeles, CA, USA., Gamis AS; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA., Aplenc R; Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Kolb EA; Nemours Center for Cancer and Blood Disorders, Emory University, Atlanta GA, USA., Alonzo TA; University of Southern California, Los Angeles, CA, USA., Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Qutub AA; Department of Biomedical Engineering, The University of Texas at San Antonio, USA;., De Bont ESJM; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Horton TM; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA., Kornblau SM; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. skornblau@mdanderson.org.
Publikováno v:
Haematologica [Haematologica] 2022 Oct 01; Vol. 107 (10), pp. 2329-2343. Date of Electronic Publication: 2022 Oct 01.
Autor:
van Dijk AD; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Divison of Pediatric Oncology/Hematology, Groningen, The Netherlands., Hoff FW; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Divison of Pediatric Oncology/Hematology, Groningen, The Netherlands.; Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA., Qiu Y; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Gerbing RB; COG Statistics and Data Center, Monrovia, California, USA., Gamis AS; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA., Aplenc R; Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Kolb EA; Nemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for Children, Wilmington, Delaware, USA., Alonzo TA; Keck School of Medicine, University of Southern California, California, USA., Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Jenkins GN; Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer Center, Houston, Texas, USA., de Bont ESJM; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Divison of Pediatric Oncology/Hematology, Groningen, The Netherlands., Kornblau SM; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Horton TM; Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer Center, Houston, Texas, USA.
Publikováno v:
Proteomics. Clinical applications [Proteomics Clin Appl] 2022 Mar; Vol. 16 (2), pp. e2100072. Date of Electronic Publication: 2021 Nov 17.
Autor:
Armandari I; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands.; Department of Histology and Cell Biology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Sekip Utara, 55281, Yogyakarta, Indonesia., Zomerman WW; Department of Pediatric Oncology and Hematology/Pediatrics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., Plasschaert SLA; Princess Máxima Center for Pediatric Oncology, Lundlaan 6, 3584 EA, Utrecht, The Netherlands., Smit MJ; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands., Martini TEI; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands., de Camargo Magalhães ES; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands.; Glial Cell Biology Laboratory, Biomedical Sciences Institute, Federal University of Rio de Janeiro, Rio de Janeiro, 21949-590, Brazil., Hogeling SM; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., Rozema-Huizinga GC; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands., Lourens HJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., Meeuwsen-de Boer TGJ; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., Scherpen FJG; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., de Bont ESJM; Department of Pediatric Oncology and Hematology/Pediatrics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., Bruggeman SWM; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands. s.w.m.bruggeman@umcg.nl.
Publikováno v:
Scientific reports [Sci Rep] 2021 Aug 09; Vol. 11 (1), pp. 16077. Date of Electronic Publication: 2021 Aug 09.
Autor:
Li, Lei1,2 (AUTHOR), Zhao, Zijuan3 (AUTHOR), Liu, Zihao1,2 (AUTHOR), Tang, Yuquan1 (AUTHOR), Yang, Tan1 (AUTHOR), Gong, Nailin1 (AUTHOR), Liao, Bing1,2,4,5 (AUTHOR), Long, Yang4 (AUTHOR), Nie, Yongmei1,2 (AUTHOR) nieyongmei@126.com, Yu, Fengxu1,2 (AUTHOR) yuluchuan@163.com
Publikováno v:
BMC Genomics. 10/25/2024, Vol. 25 Issue 1, p1-13. 13p.
Autor:
Hoff FW; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van Dijk AD; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Qiu Y; Department of Leukemia and., Ruvolo PP; Department of Leukemia and.; Section of Molecular Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX., Gerbing RB; COG Statistics and Data Center, Monrovia, CA., Leonti AR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Jenkins GN; Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer and Hematology Centers, Houston, TX., Gamis AS; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO., Aplenc R; Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, PA., Kolb EA; Nemours/Alfred I. duPont Hospital for Children, Atlanta, GA., Alonzo TA; COG Statistics and Data Center, Monrovia, CA.; Keck School of Medicine, University of Southern California, Los Angeles, CA; and., Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., de Bont ESJM; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Bruggeman SWM; European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kornblau SM; Department of Leukemia and., Horton TM; Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer and Hematology Centers, Houston, TX.
Publikováno v:
Blood [Blood] 2021 Feb 25; Vol. 137 (8), pp. 1050-1060.